Thiotepa intrathecal injections for myelomatous central nervous system involvement.

MLA

Claudel, Alexis, et al. “Thiotepa Intrathecal Injections for Myelomatous Central Nervous System Involvement.” British Journal of Haematology, vol. 193, no. 2, Apr. 2021, pp. e9–12. EBSCOhost, https://doi.org/10.1111/bjh.17343.

APA

Claudel, A., Talbot, A., Harel, S., Royer, B., Naelle, L., Zagdanski, A., Madelaine, I., Lemaire, P., & Arnulf, B. (2021). Thiotepa intrathecal injections for myelomatous central nervous system involvement. British Journal of Haematology, 193(2), e9–e12. https://doi.org/10.1111/bjh.17343

Chicago

Claudel, Alexis, Alexis Talbot, Stéphanie Harel, Bruno Royer, Lombion Naelle, Anne‐Marie Zagdanski, Isabelle Madelaine, Pierre Lemaire, and Bertrand Arnulf. 2021. “Thiotepa Intrathecal Injections for Myelomatous Central Nervous System Involvement.” British Journal of Haematology 193 (2): e9–12. doi:10.1111/bjh.17343.